前列地尔联合奥曲肽治疗对高脂血症性急性胰腺炎患者血淀粉酶阴转率的影响研究

Alprostadil Combined With Octreotide in the Treatment of Patients With Hyperlipidemia and AP Negative Conversion Rate of Amylase

目的观察前列地尔与奥曲肽用于高脂血症性急性胰腺炎患者治疗中的临床效果。方法选取来我院就诊的80例高脂血症性急性胰腺炎患者进行研究,将其分为治疗组与对照组,各40例,对照组采用奥曲肽进行常规治疗,治疗组使用前列地尔与奥曲肽进行联合治疗,对比两组治疗后的临床效果。结果治疗组的血淀粉酶阴转率与临床效果明优于对照组,差异有统计学意义(P<0.05)。结论对高脂血症性急性胰腺炎患者采用前列地尔与奥曲肽联合治疗,效果显著。

Objective To observe the effect of alprostadil combined with octreotide used in the clinical effect in the treatment of patients with hyperlipidemia hyperlipidemia acute pancreatitis. Methods In our hospital 80 cases of hyperlipidemia hyperlipidemia acute pancreatitis patients were studied and divided into treatment group and control group with 40 cases in each. The control group were treated with octreotide, the treatment group using alprostadil combined with octreotide combined therapy, compared two groups of treatment the clinical effect. Results The treatment group, the blood amylase negative rate and the clinical effect was significantly higher than the control group,P〈0.05, there was statistical significance. Conclusion The combined treatment with Alprostadil Combined with octreotide in patients with hyperlipidemic acute pancreatitis, significant effect.